Ribomic (TSE:4591) Total Operating Expense: 円1,210.13 Mil (TTM As of Mar. 2026)


TSE:4591 Ribomic Inc TSE:4591
25 GF Score
Price 円61.00
! 3 Warning Signs
View Full Analysis

What is Ribomic Total Operating Expense?

Ribomic TSE:4591 25 Total Operating Expense is 円1,210.13 Mil as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Ribomic's Total Operating Expense for the six months ended in Mar. 2026 was 円671.90 Mil. Ribomic's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,210.13 Mil.

Ribomic Total Operating Expense Related Terms

Ribomic Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Ribomic's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Total Operating Expense Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,829.02 1,852.01 1,116.19 1,052.70 1,210.13

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 534.39 514.54 538.15 538.23 671.90
TSE:4591
25GF Score
Ribomic Inc TSE:4591
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円1,210.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of 円1,210.13 Mil mean?
Ribomic (TSE:4591) has a Total Operating Expense of 円1,210.13 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ribomic and its competitors.
Is Ribomic's Total Operating Expense too high?
Ribomic's current Total Operating Expense is 円1,210.13 Mil. Overall, Ribomic has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's Total Operating Expense compare to VRTX and REGN?
Ribomic's Total Operating Expense of 円1,210.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ribomic and its competitors. Ribomic's current Total Operating Expense is 円1,210.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current Total Operating Expense of 円1,210.13 Mil. The current Total Operating Expense is 円1,210.13 Mil. Ribomic's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Ribomic (TSE:4591), the current Total Operating Expense is 円1,210.13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
25GF Score

Get the complete analysis for TSE:4591

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円61.00
Price